background image

Paid Clinical Trials Des Moines

Discover 248 paid clinical trials in Des Moines, Iowa. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Sleep for Stroke Management and Recovery Trial

for
Ischemic Stroke, Sleep Apnea, Sleep Apnea, Obstructive, Stroke,
Location: 73 recruiting locations
Sponsor: University of Michigan

Sex: All

Age: 18+

Code: NCT03812653

Recruiting
Active & Responsive

A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy

for
Geographic Atrophy, Macular Degeneration
Location: 47 recruiting locations
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 0+

Code: NCT06779773

Recruiting
Active & Responsive

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

for
Diabetes Mellitus, Type 2, PreDiabetes, Metabolic Syndrome
Location: 89 recruiting locations
Sponsor: Cleerly, Inc.

Sex: All

Age: 55+

Code: NCT06112418

Recruiting
Active & Responsive

Fenofibrate for Prevention of DR Worsening

for
Diabetic Retinopathy
Location: 58 recruiting locations
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 18 - 70+

Code: NCT04661358

Phase3, Recruiting
New

A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin

for
Diabetes Mellitus, Type 2
Location: 20 recruiting locations
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70

Code: NCT07215312

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
New

Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus

for
Obese, Obesity
Location: 11 recruiting locations
Sponsor: Hanmi Pharmaceutical Company Limited

Sex: All

Age: 18 - 70+

Code: NCT07205900

Phase2, Recruiting

A Study to Evaluate the Effect of Venetoclax on Participants Receiving a Covalent Bruton's Tyrosine Kinase Inhibitor (cBTKi) for First-line Chronic Lymphocytic Leukemia (1L CLL) to Achieve Deep Durable Remissions to Allow Off-treatment Period.

for
Chronic Lymphocytic Leukemia
Location: 19 recruiting locations
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT06524375

Phase2, Recruiting

Remote Ischemic Conditioning Using the autoRIC

for
Ischemia-Reperfusion Injury
Location: 15 recruiting locations
Sponsor: CellAegis US, Inc.

Sex: All

Age: 18+

Code: NCT03318575

Recruiting

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

for
Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma,
Location: 81 recruiting locations
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05890352

Phase2, Recruiting

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

for
Breast Cancer
Location: 120 recruiting locations
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06492616

Phase3, Recruiting